Neuroinflammation further exacerbates dysbiosis by altering intestinal motility, mucus secretion, and the immune environment, and in patients with AD, reduced diversity of intestinal flora is highly correlated with Aβ deposition and tau protein phosphorylation in the brain (Hung et al., 2022). Here, MAPT is linked to Alzheimer disease.